145 related articles for article (PubMed ID: 2524142)
21. [Mycosis of the feet: therapy].
Beurey J; Weber M; Mougeolle JM
Phlebologie; 1969; 22(1):83-90. PubMed ID: 5775651
[No Abstract] [Full Text] [Related]
22. [Lamisil in the therapy of foot mycoses].
Vladimirov VV
Ter Arkh; 1993; 65(10):71-3. PubMed ID: 8296240
[TBL] [Abstract][Full Text] [Related]
23. A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize.
Zaias N; Drachman D
J Am Acad Dermatol; 1983 Dec; 9(6):912-9. PubMed ID: 6315789
[TBL] [Abstract][Full Text] [Related]
24. Long term post-treatment follow-up of onychomycoses treated with ketoconazole.
Török I; Stehlich G
Mykosen; 1986 Aug; 29(8):372-7. PubMed ID: 2945108
[No Abstract] [Full Text] [Related]
25. Consensus of the role and positioning of the imidazoles in the treatment of dermatophytosis.
Jones HE
Acta Derm Venereol Suppl (Stockh); 1986; 121():139-46. PubMed ID: 2940792
[TBL] [Abstract][Full Text] [Related]
26. Dermatophytosis. A review of diagnosis and current therapy.
DeLauro TM; Hodge W
Clin Podiatr Med Surg; 1986 Jul; 3(3):427-32. PubMed ID: 2943391
[TBL] [Abstract][Full Text] [Related]
27. [Experience in treating onychomycosis taking into account the clinical, epidemiological and pathogenetic characteristics of the disease].
Fomin KF; Alekseeva LP; Severin MG; Sviatenko BG
Vestn Dermatol Venerol; 1979 Apr; (4):53-6. PubMed ID: 155368
[No Abstract] [Full Text] [Related]
28. [Immunological indices of rubromycosis patients in relation to the clinical manifestations of the disease and the area of the skin lesion foci].
Sultanaliev KA
Vestn Dermatol Venerol; 1984 Feb; (2):65-7. PubMed ID: 6232774
[No Abstract] [Full Text] [Related]
29. [Study of remote results of griseofulvin treatment of trichophytosis of the feet and hands].
Baranov AF; Arievich AM
Vestn Dermatol Venerol; 1975 Jul; (7):75-9. PubMed ID: 130030
[No Abstract] [Full Text] [Related]
30. [Ketoconazole and onychomycosis].
Parent D; Achten G; André J; Wiame L
Ann Dermatol Venereol; 1984; 111(4):339-44. PubMed ID: 6089641
[TBL] [Abstract][Full Text] [Related]
31. Onychomycosis. Agents of choice.
Hay RJ
Dermatol Clin; 1993 Jan; 11(1):161-9. PubMed ID: 8382121
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of dermatomycoses with 1% canesten cream].
Banaszkiewicz H
Przegl Dermatol; 1981; 68(3):399-401. PubMed ID: 6458073
[No Abstract] [Full Text] [Related]
33. The systemic treatment of onychomycosis.
Wenig JA
Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500
[TBL] [Abstract][Full Text] [Related]
34. The systemic treatment of onychomycosis.
Wenig JA
Clin Podiatr Med Surg; 2004 Oct; 21(4):579-89, vi. PubMed ID: 15450898
[TBL] [Abstract][Full Text] [Related]
35. [The nonspecific correction of phagocytosis in patients with foot mycoses].
Svirid SG
Vrach Delo; 1989 Nov; (11):99-100. PubMed ID: 2609600
[TBL] [Abstract][Full Text] [Related]
36. [Basis and comparative evaluation of the combined therapy of patients with foot and hand mycoses].
Ruslanov DV
Vestn Dermatol Venerol; 1985 Sep; (9):68-70. PubMed ID: 4090716
[No Abstract] [Full Text] [Related]
37. [Considerations on the results obtained in the Clinica Dermosifilopatica di Cagliari with the use of griseofulvin in the treatment of dermatophytosis].
Biggio P
Minerva Dermatol; 1966 Jul; 41(7):233-7. PubMed ID: 4230239
[No Abstract] [Full Text] [Related]
38. [Rubromycosis].
Shaposhnikov OK; Krupko MI
Voen Med Zh; 1981 Oct; (10):64-6. PubMed ID: 6458151
[No Abstract] [Full Text] [Related]
39. [The function of the hypophysis-thyroid system in patients with rubromycosis].
Politov VF; Kachuk MV; Iagovdik NZ
Vestn Dermatol Venerol; 1989; (9):16-8. PubMed ID: 2532818
[TBL] [Abstract][Full Text] [Related]
40. Tinea unguium.
Daniel CR; Lawson LA
Cutis; 1987 Oct; 40(4):326-7. PubMed ID: 2960495
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
